Penn Medicine is committed to providing exceptional training to those pursuing a career in hematology oncology.
The hematology/oncology fellowship program at Penn is designed to provide our trainees with the tools they need to pursue lifelong careers characterized by excellence, innovation and commitment. It is the aim of the division to ensure that trainees completing our training become leaders in the field of hematology/oncology, whether they pursue careers in clinical, population science or bench research.
Each and every member of the division is dedicated to the education and career development of its fellows. Roger B. Cohen, MD, is the Fellowship Program Director. An experienced clinician and clinical researcher, his clinical interests include the care of patients with solid malignancies with a focus on lung cancer and head and neck cancer. His research interests include experimental therapeutics and clinical trial design and analysis with an emphasis on biological therapies, including immunotherapy.
Penn fellows have the opportunity to train in a broad array of basic science laboratories across our large and diverse campus, and our fellows here work in departments and schools throughout the University of Pennsylvania, as well as the Children's Hospital of Philadelphia, the Abramson Cancer Center and Abramson Family Cancer Research Institute and the Wistar Institute.
Master's Degree Programs
Penn offers four master's degree programs in which fellows may participate:
The Abramson Family Cancer Research Institute, is home to a large proportion of the cancer research on campus. Research programs in benign hematology can be accessed through the Penn Comprehensive Hemophilia and Thrombosis Research Program and by reviewing the home pages of individual faculty members in that program.
Links for Current Hematology/Oncology Fellows
For more information, contact:
Program Coordinator, Hematology/Oncology Fellowship
Perelman School of Medicine